Stockholm - Delayed Quote • SEK Implantica AG (IMP-A-SDB.ST) Follow Compare 36.30 -0.20 (-0.55%) At close: January 17 at 5:24:54 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Implantica presents the second quarter 2024 on August 21 at 15:00 CEST Implantica AG (publ) invites investors to a presentation of the second quarter 2024 at 15:00 CEST on August 21. The interim report for the second quarter will be published at 8:00 a.m. CEST on the same day. Implantica launches RefluxStop™ advanced education program in Spain Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, brings together top anti-reflux surgeons in Spain to create a community of excellence to share RefluxStop™ data, insights, and the best practices, driving advancements in the surgical treatment field of gastroesophageal reflux disease (GERD). Implantica publishes Annual Report 2023 Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. Implantica's RefluxStop™ now available in Munich Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStop™ procedures completed at Artemed Klinikum München Süd in Munich, Germany. Performance Overview Trailing total returns as of 1/18/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD Return IMP-A-SDB.ST MSCI WORLD YTD +5.52% +1.59% 1-Year +26.26% +21.07% 3-Year -31.38% 0.00%